INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE);UNIVERSITE PARIS DESCARTES
发明人:
Alain Hovnanian,Magali Savignac
申请号:
US14361319
公开号:
US20140350049A1
申请日:
2012.11.29
申请国别(地区):
US
年份:
2014
代理人:
摘要:
The present invention relates to methods and pharmaceutical compositions for the treatment of Darier disease. More particularly, the present invention relates to an agent that is able to restore E-cadherin trafficking in DK and the formation of adherens junctions for use in a method for treating patients with Darier disease. In particular, the present invention relates to an agent selected from the group consisting of molecular, chemical and pharmacologic chaperones for use in a method for treating patients with Darier disease.